Healthcare >> CEO Interviews >> June 18, 2001

Michael Martino – Sonus Pharmaceuticals (snus)

MICHAEL A. MARTINO is President, Chief Executive Officer and a Director of Sonus Pharmaceuticals Inc. Mr. Martino joined Sonus in September 1998 as President, Chief Operating Officer and a Director and was appointed Chief Executive Officer in July 1999. From 1983 to 1998, he held numerous positions of increasing responsibility in strategic planning, business development, marketing and sales, and general management with Mallinckrodt, Inc., a global healthcare products company, including serving as Vice President and General Manager of the Nuclear Division. Mr. Martino received a BA in Business from Roanoke College and an MBA from Virginia Tech. He sits on the Presidents Advisory Board of Roanoke College and is a member of the Board of Trustees of Cascadia Community College. In addition, Mr. Martino is a past Chairman of the Board of the Washington Biotechnology and Biomedical Association (WBBA). Profile
TWST: Could we begin with a brief historical sketch and overview of

Sonus Pharmaceuticals?

Mr. Martino: Sonus was founded in 1991 and went public in 1995. The

founding strategy of the company